Search For HIV Vaccine Threatened by U.S. Aid Cut

Funding for a groundbreaking project by a group of researchers - who have already made significant contributions to advancing the world's understanding of HIV - has been derailed as a result of the U.S. government's decision on aid.  The project brings together researchers from about eight African countries under the aegis of the BRILLIANT Consortium.

While the use of antiretroviral treatment has proven to be effective in keeping people living with HIV healthy, experts say it is not a cure. They note that the development of an HIV vaccine remains vital to ending the epidemic.

Three decades of research have failed to develop a cure for the disease - because HIV "continues to evade the immune system". A consensus has, however, emerged among researchers that to be effective, an HIV vaccine must be able to induce "broadly neutralizing antibodies". 

The BRILLIANT Consortium says it is at the "cutting edge of developing and testing these new approaches".

InFocus

Professor Glenda Gray, President of the South African Medical Research Council, is the first author on a study about an HIV vaccine being tested in South Africa (file photo).

AllAfrica publishes around 500 reports a day from more than 110 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.